These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35225469)

  • 21. Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma.
    Zoetemelk M; Rausch M; Colin DJ; Dormond O; Nowak-Sliwinska P
    Sci Rep; 2019 May; 9(1):7103. PubMed ID: 31068603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the spheroid model complexity on drug response.
    Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
    J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
    Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
    Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells.
    Weydert Z; Lal-Nag M; Mathews-Greiner L; Thiel C; Cordes H; Küpfer L; Guye P; Kelm JM; Ferrer M
    SLAS Discov; 2020 Mar; 25(3):265-276. PubMed ID: 31658853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma - a Review.
    Ayvaz I; Sunay D; Sariyar E; Erdal E; Karagonlar ZF
    J Gastrointest Cancer; 2021 Dec; 52(4):1294-1308. PubMed ID: 34927218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
    Calpe B; Kovacs WJ
    Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies.
    Monteiro MV; Gaspar VM; Mendes L; Duarte IF; Mano JF
    Small Methods; 2021 May; 5(5):e2001207. PubMed ID: 34928079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
    Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
    Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applicability of tumor spheroids for
    Hamilton G; Rath B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro evaluation of doxorubicin release from diopside particles on MG-63 and HF spheroids as a 3D model of tumor and healthy tissues.
    Bulygina IN; Karshieva SS; Permyakova ES; Korol AA; Kolesnikov EA; Choudhary R; Senatov FS; Koudan EV
    Toxicol In Vitro; 2024 Jun; 98():105830. PubMed ID: 38641231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening.
    Griner LM; Gampa K; Do T; Nguyen H; Farley D; Hogan CJ; Auld DS; Silver SJ
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30247463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an
    Lee J; Shin D; Roh JL
    Theranostics; 2018; 8(14):3964-3973. PubMed ID: 30083273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma.
    Ortiz Jordan LM; Vega VF; Shumate J; Peles A; Zeiger J; Scampavia L; Spicer TP
    SLAS Discov; 2024 Apr; 29(3):100141. PubMed ID: 38218316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
    Lama R; Zhang L; Naim JM; Williams J; Zhou A; Su B
    Bioorg Med Chem; 2013 Feb; 21(4):922-31. PubMed ID: 23306053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional culture models to study drug resistance in breast cancer.
    Fisher MF; Rao SS
    Biotechnol Bioeng; 2020 Jul; 117(7):2262-2278. PubMed ID: 32297971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells.
    Bregenzer ME; Davis C; Horst EN; Mehta P; Novak CM; Raghavan S; Snyder CS; Mehta G
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31329171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Issues with Cancer Spheroid Models in Therapeutic Drug Screening.
    Fröhlich E
    Curr Pharm Des; 2020; 26(18):2137-2148. PubMed ID: 32067603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput CRISPR-mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistance.
    Grandhi TSP; To J; Romero A; Luna F; Barnes W; Walker J; Moran R; Newlin R; Miraglia L; Orth AP; Horman SR
    Biotechnol Bioeng; 2021 Aug; 118(8):3187-3199. PubMed ID: 34050941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Three-dimensional (3D) Tumor Cell Culture Systems and Mechanism of Drug Resistance.
    Shehzad A; Ravinayagam V; AlRumaih H; Aljafary M; Almohazey D; Almofty S; Al-Rashid NA; Al-Suhaimi EA
    Curr Pharm Des; 2019; 25(34):3599-3607. PubMed ID: 31612821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-Dimensional (3D) Culture Models in Cancer Investigation, Drug Testing and Immune Response Evaluation.
    Benelli R; Zocchi MR; Poggi A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.